**GLP-1 Drugs Cut Colon Cancer Deaths by 50%, Especially for High-BMI Patients**
GLP-1 Drugs Slash Colon Cancer Mortality by Half: Study A landmark study reveals that GLP-1 receptor agonists—used for diabetes and weight loss—reduce colon cancer deaths by 52% (15.5% mortality vs. 37.1%). The effect was most…